Article Information
History
- April 30, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Wing Leung1,2,†,
- Teck Guan Soh*,3,
- Yeh Ching Linn*,2,4,
- Jenny Guek-Hong Low2,5,
- Jiashen Loh6,
- Marieta Chan7,
- Wee Joo Chng3,8,
- Liang Piu Koh3,8,
- Michelle Li-Mei Poon3,8,
- King Pan Ng1,
- Chik Hong Kuick9,
- Thuan Tong Tan2,5,
- Lip Kun Tan3,8,† and
- Michaela Su-fern Seng1,2
- 1Department of Haematology/Oncology, KK Hospital, SingHealth, Singapore
- 2Duke-NUS Medical School, Singapore
- 3Department of Haematology-Oncology, National University Hospital, Singapore
- 4Department of Haematology, Singapore General Hospital, Singapore
- 5Department of Infectious Disease, Singapore General Hospital, Singapore
- 6Department of Infectious Disease, Sengkang General Hospital, Singapore
- 7Blood Services Group, Health Sciences Authority, Singapore
- 8Yong Loo Lin School of Medicine, National University of Singapore, Singapore
- 9Department of Pathology and Laboratory Medicine, KK Hospital, SingHealth, Singapore
- ↵†Correspondence to: Prof Wing Leung (leung.wing.hang{at}singhealth.com.sg); Dr. Lip Kun Tan (lip_kun_tan{at}nuhs.edu.sg)
↵* Contributed equally
Posted April 30, 2020.
SUCCESSFUL MANUFACTURING OF CLINICAL-GRADE SARS-CoV-2 SPECIFIC T CELLS FOR ADOPTIVE CELL THERAPY
